Login
Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Download Documents
Get Help to Participate in This Tender
CHILDREN'S UNIVERSITY HOSPITAL WITH POLYCLINIC BANSKA BYSTRICA has floated a tender for A Drug with the Active Substance of Blinatumomab. The project location is Slovakia and the tender is closing on 23 Jul 2025. The tender notice number is 366899-2025, while the TOT Ref Number is 120441569. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.
Procurement Summary
Country : Slovakia
Summary : A Drug with the Active Substance of Blinatumomab
Deadline : 23 Jul 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 120441569
Document Ref. No. : 366899-2025
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : EUR 165611.2
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
The subject of the order is: the drug with the active substance Blinatumomab 38.5 micrograms powder for the infusion concentrate and the solution for the preparation of the infusion solution with a concentration of 12.5 micrograms/ml. One powder vial contains 38.5 micrograms of blinatumomab. Reconstitution with water for injections is obtainedFinal Blinatumomab concentration 12.5 micrograms/ml. The drug is indicated as a monotherapy of pediatric patients 1 or more months for the treatment of ALL from B-cell precursors with negative philadelphia chromosome and positive CD19, which is refractory or relay after completing at least twoPrevious treatment or relay after receiving a previous allogeneous transplantation of hematopoietic stem cells. The drug is indicated as a monotherapy of pediatric patients 1 or more months for the treatment of ALL from precursors of B-cell precursors with negative philadelphia chromosome, positiveCD19 and high risk in the first relapse as part of the consolidation treatment. One powder vial contains 38.5Blinatumomab micrograms. Reconstitution with water for injections is obtained by the final concentration of Blinatumomab 12.5 micrograms/ml. The drug is indicated as a monotherapy of pediatric patients 1 or more months to treat All from B-cell precursors with negative philadelphia chromosome anditem ...
Document Type: Contract Notice
Reference Number: 61-2025
Contract Type: supplies
Estimated Value: 165611.2 - EUR
Authority Type: body-pl-cga
Doc Title: Liek s učinnou latkou blinatumomab
Dispatch Date: 2025-06-04
Publish Date: 2025-06-06
Submission Date: 2025-07-23
Documents
Procurement Documents for Slovakia
Access a comprehensive library of standard procurement documents specific to Slovakia. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in Slovakia
Want To Bid in This Tender?
Get Local Agent Support in Slovakia and 60 More Countries.
View Tenders By
Sign in with Google